Watch AKTS. Know when insiders buy.
One email the day a filing lands. Free.
AKTS
Aktis Oncology, Inc.
19.63
−0.09 −0.46%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
71
PASS · shorts 71
Insiders, 90 days
−$259K
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 15.19 – 32.23
Insider trading
−$259K
Net, 90 days
0 / 2
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 23 | Sep 24 | Czibere Akos · Chief Medical Officer | Sell | 7,401 | $21.03 | $156K |
| Sep 23 | Sep 24 | Czibere Akos · Chief Medical Officer | Sell | 5,099 | $20.19 | $103K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.